This National Cancer Institute (NCI) grant, the SBIR Phase IIB Bridge Award, is for small business concerns seeking additional funding to advance cancer-relevant technologies toward commercialization. Its purpose is to facilitate the transition of projects previously funded under any federal SBIR or STTR Phase II award into their next development stage. The grant aims to promote partnerships between awardees and third-party investors or strategic partners, accelerating the capital-intensive steps required for commercialization. Applicants must provide a Commercialization Plan detailing independent third-party investor funding, which should match or exceed the NCI funds requested. Proposed projects can encompass preclinical and/or clinical technology development, with clinical trials being optional.
Opportunity ID: 353723
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-24-022 |
| Funding Opportunity Title: | SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Apr 23, 2024 |
| Last Updated Date: | Apr 23, 2024 |
| Original Closing Date for Applications: | Aug 21, 2024 |
| Current Closing Date for Applications: | Aug 21, 2024 |
| Archive Date: | Sep 26, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that seek additional funding to support the next stage of development for cancer-relevant projects that were previously funded under SBIR or STTR Phase II awards from any Federal agency. The purpose of this NOFO is to facilitate the transition of SBIR or STTR Phase II projects to the commercialization stage. This NOFO is expected to promote partnerships between Federally-funded SBIR or STTR Phase II awardees and third-party investors and/or strategic partners to facilitate and accelerate the capital-intensive steps that are required to commercialize new products and services. Applicants must submit a Commercialization Plan, which should include details on any independent third-party investor funding that has already been secured or is anticipated during the Phase IIB Bridge Award project period. It is expected that the level of this independent third-party funding will be equal to or greater than the NCI funds being requested throughout the Phase IIB Bridge Award project period. Proposed projects may address preclinical and/or clinical stages of technology development. Clinical trials may be proposed as appropriate but are not required. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-24-022.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 353723 Full Announcement-RFA-CA-24-022 -> RFA-CA-24-022-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00286016 | Jul 21, 2024 | Aug 21, 2024 | View |
Package 1
Mandatory forms
353723 RR_SF424_5_0-5.0.pdf
353723 PHS398_CoverPageSupplement_5_0-5.0.pdf
353723 RR_OtherProjectInfo_1_4-1.4.pdf
353723 PerformanceSite_4_0-4.0.pdf
353723 RR_KeyPersonExpanded_4_0-4.0.pdf
353723 RR_Budget_3_0-3.0.pdf
353723 PHS398_ResearchPlan_5_0-5.0.pdf
353723 SBIR_STTR_Information_3_0-3.0.pdf
353723 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
353723 RR_SubawardBudget30_3_0-3.0.pdf
353723 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
